Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Parkinson's disease
Age: Adult
Condition: As an adjunct to levodopa
Dose: Tablet – 1-1.25 mg
Frequency: at night
Duration: 1st week
Indication: Parkinson's disease
Age: Adult
Condition: As an adjunct to levodopa
Dose: Tablet – 2-2.5 mg
Frequency: at night
Duration: 2nd week

Child Dose

Clinical InformationAdministration Information
Indication: Hyperprolactinemia
Age: 11-15 years
Condition: Initially
Dose: Oral Tablet – 1.25-2.5 mg
Frequency: once daily
Note: by mouth (oral)
Indication: Hyperprolactinemia
Age: 11-15 years
Condition: Maintenance
Dose: Oral Tablet – 2.5-10 mg/day
Note: by mouth (oral)

Renal Dose

Clinical InformationAdministration Information
Condition: Renal impairment
Dose: Dose:
Note: Safety and efficacy has not been established
Administration
  • Should be taken with food
  • Start with low dose
Side Effect

Drug Interaction

Drug NameRisk Factors
Erythromycin
Increased bioavailability
Alcohol
Reduces tolerance to bromocriptine and vice-versa

Disease Interaction

Disease NameRisk Factors
Breast Carcinoma
Risk of tumor growth
Hypersensitivity to Ergot Alkaloids
Risk of severe allergic reaction

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.